Genetic and Basic Metabolite & Enzyme testing
No data was provided | |
Available molecular techniques:
Tests that are being offered in this lab | |||
Amino and organic acids disorders (AOA) | |||
Fatty Acid Oxidation (FAO Disorders) | |||
Lysosomal Storage Disorders (LSD) | |||
Peroxisomal Disorders (PD) | |||
Congenital Disorders of glycosylation and Disorders of intracellular trafficking (CDG) | |||
Disorders of Neuromodulators and other small Molecules (NOMS) | |||
Disorders of Pyruvate Metabolism, Krebs cycle defects, mitochondrial oxidative phosphorylation disorders, disorders of thiamine transport and metabolism (PM-MD) | |||
Metabolic Laboratory Freiburg | https://ims.uniklinik-freiburg.de/en/medical-services/clinics-and-divisions/institute-for-clinical-chemistry-and-laboratory-medicine-lipid-metabolism-center.html
|
Contact person Sara Tucci | sara.tucci@uniklinik-freiburg.de |
Metabolite Tests | |
Type of Test | Name of |
Amino and organic acids disorders (AOA) | |
Urine | Amino acids quantitative, |
Carnitine Total, Free, | |
Formiminoglutamic acid (FIGLU), | |
Glycerate, | |
Glycolic Acid, | |
Organic acids qualitative, | |
Organic acids quantitative, | |
Orotic acid, | |
Succinylacetone, | |
Sulfite test, | |
S-Sulfocysteine, | |
Plasma
|
Plasma: Amino acids quantitative, |
Plasma: Acylcarnitines, | |
Plasma: Carnitine, free and total, | |
Plasma: Methylmalonic acid (MMA), | |
Plasma: Organic acids profile, | |
Plasma: Total homocysteine, | |
Plasma: S-adenosylhomocysteine, | |
Plasma: S-adenosylmethionine, | |
Dry blood spots | Acylcarnitines, |
Total homocysteine, | |
CSF | Aminoacids |
Fatty Acid Oxidation (C-FAO Disorders) | |
Urine | Reducing substances, |
Galactitol (special assay), | |
Polyols profiling, | |
Sugars qualitative | |
Lysosomal Storage Disorders (LSD) | |
Urine
|
Glycosaminoglycans qualitative (screening tests) |
Glycosaminoglycans quantitative, | |
Mucopolysaccharide electrophoresis/TLC | |
Peroxisomal Disorders (PD) | |
Plasma
|
7-Dehydrocholesterol, |
Cholesterol, | |
Phytanic acid, | |
Very long chain fatty acids- VLCFA | |
Congenital Disorders of glycosylation and Disorders of intracellular trafficking (CDG) | |
Plasma, N-Glycosylation | N-Glycolysation HPLC (sialotransferrins) |
Disorders of Neuromodulators and other small Molecules (NOMS) | |
Urine
|
Alpha-aminoadipic semialdehyde, |
U-Copper (24h) | |
Plasma | Alpha-aminoadipic semialdehyde, |
Plasma: Purines/pyrimidines, | |
Plasma: p-Copper, | |
Plasma: p-Ceruloplasmin | |
Disorders of Pyruvate Metabolism, Krebs cycle defects, mitochondrial oxidative phosphorylation disorders, disorders of thiamine transport and metabolism (PM-MD) | |
Urine | Creatine |
Creatinine | |
Guanidinoacetate | |
Plasma | Creatine |
guanidinoacetate |
Enzyme Tests | ||
Type of Disease | Yes or No | |
Amino and organic acids disorders (AOA) | ||
Organic Acidurias | Yes | |
Aminoacidopathies | Yes | |
Urea cycle disorders | No | |
Fatty Acid Oxidation (C-FAO Disorders) | ||
Glycogen storage diseases
|
No | |
Carbohydrate diseases other than Glycogen storage diseases
|
No | |
Fatty acid oxidation and carnitine transport disorders
|
Yes | |
Disorders of Ketogenesis and Ketolysis
|
No | |
Lysosomal Storage Disorders (LSD) | ||
Mucopolysaccharidoses | Yes | |
Peroxisomal Disorders (PD) | ||
– | – | |
Congenital Disorders of glycosylation and Disorders of intracellular trafficking (CDG) | ||
– | – | |
Disorders of Neuromodulators and other small Molecules (NOMS) | ||
– | – | |
Disorders of Pyruvate Metabolism, Krebs cycle defects, mitochondrial oxidative phosphorylation disorders, disorders of thiamine transport and metabolism (PM-MD) | ||
– | – |